GlassScriptPhysician profile
Maria L Castillo
NPI 1962566489
$2,331.56
in general payments reported to CMS, 2019-2025
24 companies · $486 in 2025
The $486 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $158 · 2021: $232 · 2022: $207 · 2023: $1,052 · 2024: $32.72 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $948 · Food and Beverage: $623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $947.80 |
| Food and Beverage | $622.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $947.80 | 2023 | Da Vinci Surgical System |
| Mayne Pharma Commercial LLC | $393.45 | 2022-2025 | |
| Pfizer INC. | $209.55 | 2019-2022 | |
| Abbvie INC. | $181.02 | 2020-2023 | Orilissa, Lo Loestrin Fe |
| Shield Therapeutics INC | $88.38 | 2025 | |
| Allergan, INC. | $70.04 | 2019 | |
| Exeltis, USA INC. | $54.15 | 2020-2025 | Slynd |
| Astellas Pharma US INC | $44.04 | 2023 | Veozah |
| Hologic Sales and Service, LLC | $39.13 | 2019-2020 | |
| Myovant Sciences INC. | $37.73 | 2021-2022 | |
| Therapeuticsmd, INC. | $32.41 | 2019-2021 | |
| Avion Pharmaceuticals | $31.27 | 2020-2022 | |
| Biogen, INC. | $24.24 | 2025 | Zurzuvae |
| Teleflex LLC | $21.93 | 2022 | |
| Evofem Biosciences, INC. | $20.27 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $19.06 | 2022 | |
| Amag Pharmaceuticals, INC. | $15.61 | 2019 | |
| Viiv Healthcare Company | $15.43 | 2024 | Apretude |
| Organon LLC | $14.98 | 2022 | |
| Merck Sharp & Dohme LLC | $14.91 | 2020 | |
| Aspira Women'S Health INC | $14.58 | 2022 | |
| Lupin INC. | $14.01 | 2019 | |
| Ethicon US, LLC | $13.99 | 2021 | |
| Sumitomo Pharma America, INC. | $13.58 | 2023 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Castillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.